OFIX - Orthofix Medical Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Lewisville,
United States
Type: Equity
OFIX price evolution
OFIX
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $28.87 | $29.46 | $37.76 | |
| Short term investments | ||||
| Net receivables | $124.84 | $125.36 | $125.62 | $128.1 |
| Inventory | $205.81 | $210.04 | $219.08 | $222.17 |
| Total current assets | $386.21 | $386.06 | $398.98 | $420.44 |
| Long term investments | ||||
| Property, plant & equipment | $164.74 | $154.11 | $158.13 | $159.06 |
| Goodwill & intangible assets | $303.24 | $307.69 | $312.42 | |
| Total noncurrent assets | $495.93 | $507.07 | $504.87 | |
| Total investments | ||||
| Total assets | $867.87 | $882 | $906.05 | $925.32 |
| Current liabilities | ||||
| Accounts payable | $47.06 | $50.36 | $57.15 | $58.36 |
| Deferred revenue | ||||
| Short long term debt | $5.42 | $3.85 | $1.96 | |
| Total current liabilities | $161.9 | $155.97 | $150.62 | $165.22 |
| Long term debt | $130.24 | $131.47 | $133.42 | $111.64 |
| Total noncurrent liabilities | $180.03 | $185.11 | $161.36 | |
| Total debt | $136.9 | $137.26 | $113.6 | |
| Total liabilities | $341.95 | $335.99 | $335.74 | $326.58 |
| Shareholders' equity | ||||
| Retained earnings | -$247 | -$219.61 | -$186.16 | -$150.14 |
| Other shareholder equity | -$0.9 | -$2.73 | -$0.66 | -$1.29 |
| Total shareholder equity | $546 | $570.32 | $598.73 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $37.76 | $50.7 | $87.85 | $96.82 |
| Short term investments | ||||
| Net receivables | $128.1 | $82.86 | $78.56 | $72.42 |
| Inventory | $222.17 | $100.15 | $82.97 | $84.64 |
| Total current assets | $420.44 | $255.99 | $269.52 | $270.38 |
| Long term investments | ||||
| Property, plant & equipment | $159.06 | $65.02 | $59.25 | $63.61 |
| Goodwill & intangible assets | $312.42 | $118.7 | $123.98 | $144.53 |
| Total noncurrent assets | $504.87 | $202.64 | $207.1 | $255.48 |
| Total investments | ||||
| Total assets | $925.32 | $458.63 | $476.62 | $525.86 |
| Current liabilities | ||||
| Accounts payable | $58.36 | $27.6 | $26.46 | $23.12 |
| Deferred revenue | ||||
| Short long term debt | $1.96 | $0.65 | $2.59 | $0.51 |
| Total current liabilities | $165.22 | $83.62 | $105.83 | $103.9 |
| Long term debt | $111.64 | $19.24 | $19.89 | $22.34 |
| Total noncurrent liabilities | $161.36 | $38.15 | $33.86 | $65.1 |
| Total debt | $113.6 | $19.89 | $22.48 | $22.85 |
| Total liabilities | $326.58 | $121.77 | $139.69 | $169 |
| Shareholders' equity | ||||
| Retained earnings | -$150.14 | $1.25 | $21 | $59.38 |
| Other shareholder equity | -$1.29 | -$1.48 | $3.25 | |
| Total shareholder equity | $598.73 | $336.86 | $336.93 | $356.86 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $196.61 | $198.62 | $188.61 | $200.41 |
| Cost of revenue | $63.87 | $61.37 | $63.78 | |
| Gross Profit | $135.05 | $134.75 | $127.24 | $136.63 |
| Operating activities | ||||
| Research & development | $18.05 | $19.49 | $18.94 | |
| Selling, general & administrative | $134.22 | $131.69 | $132.28 | |
| Total operating expenses | $153.95 | $159.66 | $156.58 | $154.94 |
| Operating income | -$24.91 | -$29.34 | -$18.32 | |
| Income from continuing operations | ||||
| EBIT | -$27.42 | -$30.61 | -$17.55 | |
| Income tax expense | $0.75 | $1.08 | $0.85 | $0.13 |
| Interest expense | -$5.21 | $4.94 | $4.56 | $4.5 |
| Net income | ||||
| Net income | -$27.39 | -$33.44 | -$36.02 | -$22.17 |
| Income (for common shares) | -$33.44 | -$36.02 | -$22.17 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $746.64 | $460.71 | $464.48 | $406.56 |
| Cost of revenue | $260.37 | $123.54 | $114.91 | $101.89 |
| Gross Profit | $486.27 | $337.17 | $349.56 | $304.67 |
| Operating activities | ||||
| Research & development | $80.23 | $49.06 | $49.62 | $39.06 |
| Selling, general & administrative | $530.39 | $308.78 | $290.67 | $272.38 |
| Total operating expenses | $625.38 | $350.44 | $357.88 | $310.94 |
| Operating income | -$139.11 | -$13.27 | -$8.31 | -$6.27 |
| Income from continuing operations | ||||
| EBIT | -$140.05 | -$16.42 | -$11.66 | $2.12 |
| Income tax expense | $2.72 | $2.04 | $24.88 | -$2.88 |
| Interest expense | $8.63 | $1.29 | $1.84 | $2.48 |
| Net income | ||||
| Net income | -$151.4 | -$19.75 | -$38.38 | $2.52 |
| Income (for common shares) | -$151.4 | -$19.75 | -$38.38 | $2.52 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$33.44 | -$36.02 | -$22.17 | |
| Operating activities | ||||
| Depreciation | $14.03 | $14.86 | $13.97 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $9.96 | $8.8 | $3.17 | |
| Total cash flows from operations | $8.98 | -$18.59 | -$6.69 | |
| Investing activities | ||||
| Capital expenditures | -$9.72 | -$10.82 | -$15.05 | |
| Investments | ||||
| Total cash flows from investing | -$26.45 | -$9.72 | -$10.87 | -$15.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.19 | $2.75 | ||
| Net borrowings | -$1.02 | $23.28 | $22.97 | |
| Total cash flows from financing | $19.22 | $0.23 | $21.45 | $25.28 |
| Effect of exchange rate | -$0.04 | -$0.09 | -$0.28 | $0.56 |
| Change in cash and equivalents | -$5.2 | -$0.6 | -$8.29 | $4.09 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$151.4 | -$19.75 | -$38.38 | $2.52 |
| Operating activities | ||||
| Depreciation | $53.06 | $29.02 | $29.6 | $30.55 |
| Business acquisitions & disposals | $29.42 | -$1.37 | -$1.25 | -$25.24 |
| Stock-based compensation | $35.71 | $18.44 | $15.43 | $16.21 |
| Total cash flows from operations | -$45.75 | -$11.54 | $18.48 | $74.27 |
| Investing activities | ||||
| Capital expenditures | -$62.05 | -$23.16 | -$19.59 | -$17.09 |
| Investments | -$2.17 | -$10 | ||
| Total cash flows from investing | -$33.13 | -$24.53 | -$23.01 | -$52.33 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $5.13 | $4.34 | $8.82 | $7.6 |
| Net borrowings | $65.59 | -$2.69 | -$1.49 | -$1.86 |
| Total cash flows from financing | $65.32 | -$0.08 | -$3.62 | $3.25 |
| Effect of exchange rate | $0.62 | -$1 | -$0.81 | $1.24 |
| Change in cash and equivalents | -$12.94 | -$37.15 | -$8.97 | $26.42 |
News
Fundamentals
| Market cap | $685.85M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 38.21M |
| Revenue | $784.25M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$119.03M |
| Revenue Q/Q | 6.85% |
| Revenue Y/Y | 17.32% |
| P/E ratio | -5.76 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.87 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$3.12 |
|---|---|
| ROA | -13.29% |
| ROE | N/A |
| Debt/Equity | 0.55 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.39 |
| Quick ratio | 1.11 |